<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03655509</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A01386-37</org_study_id>
    <nct_id>NCT03655509</nct_id>
  </id_info>
  <brief_title>Searching a Dysfunction of Corticotropic &amp; Thyrotropin Axis During the Acute Phase of a Subarachnoid Hemorrhage Secondary to Spontaneous Rupture of Cerebral Aneurysm</brief_title>
  <acronym>HSA</acronym>
  <official_title>Searching a Dysfunction of Corticotropic and Thyrotropin Axis During the Acute Phase ( ≤48h ) of a Subarachnoid Hemorrhage Secondary to Spontaneous Rupture of Cerebral Aneurysm: Impact on the Incidence of Complications and Recovery at 1 Month</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Searching a dysfunction of corticotropic and thyrotropin axis during the acute phase ( ≤48h )
      of a subarachnoid hemorrhage secondary to spontaneous rupture of cerebral aneurysm. Impact on
      the incidence of complications and recovery are evaluated at 1 month.

      Blood sample are made within 48 hours of the onset of bleeding with assay of total plasma
      cortisol, plasma ACTH at 8 am and thyroid hormones (T3, free T4 , and TSH). Dynamic test ACTH
      stimulation (test Synacthene) with renewal of serum cortisol to H + 1 (60min). Evaluation in
      the first 30 days of the incidence of rebleeding, hydrocephalus, of vasospasm, infection and
      epilepsy. GOS to 1 month.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Searching a dysfunction of corticotropic and thyrotropin axis during the acute phase ( ≤48h )
      of a subarachnoid hemorrhage secondary to spontaneous rupture of cerebral aneurysm. Impact on
      the incidence of complications and recovery are evaluated at 1 month.

      Blood sample are made within 48 hours of the onset of bleeding with assay of total plasma
      cortisol, plasma ACTH at 8 am and thyroid hormones (T3, free T4 , and TSH). Dynamic test ACTH
      stimulation (test Synacthene) with renewal of serum cortisol to H + 1 (60min). Evaluation in
      the first 30 days of the incidence of rebleeding, hydrocephalus, of vasospasm, infection and
      epilepsy. GOS to 1 month.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ACTH stimulation test</measure>
    <time_frame>2 days</time_frame>
    <description>ACTH stimulation test compared of threshold values at 48h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ATCH levels</measure>
    <time_frame>2 days</time_frame>
    <description>ATCH levels at 8 AM compared of threshold values at 48h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma cortisol</measure>
    <time_frame>2 days</time_frame>
    <description>µg per L</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>ACTH stimulation test</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dynamic test ACTH stimulation</intervention_name>
    <arm_group_label>ACTH stimulation test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute phase ( ≤48h) of a subarachnoid hemorrhage secondary to spontaneous rupture of
             cerebral aneurysm (Glasgow coma scale &gt;=9)

        Exclusion Criteria:

          -  Pituitary failure

          -  Patient with corticosteroids drugs or antithyroid drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>September 13, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>August 30, 2018</last_update_submitted>
  <last_update_submitted_qc>August 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Rupture, Spontaneous</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

